Literature DB >> 1829046

Analgesic effects of serotonin and receptor-selective serotonin agonists in the rat spinal cord.

T Crisp1, J L Stafinsky, L J Spanos, M Uram, V C Perni, H B Donepudi.   

Abstract

1. Serotonin (5-HT) and selective 5-HT receptor agonists were administered intrathecally (i.t.) in rats, and the antinociceptive efficacy of these agents was assessed on the tail-flick and hot plate tests. 2. The 5-HT receptor agonists examined in this study included the 5-HT1A agonist 8-hydroxy-N,N-dipropyl-2-aminotetralin (8-OH-DPAT), the 5-HT1B agonist m-trifluoromethylphenylpiperazine (TFMPP), the 5-HT2 agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and the 5-HT3 agonist phenylbiguanide (PBG). 3. None of these agents produced significant elevations in tail-flick latency (TFL) at doses which produced elevations in hot plate latency (HPL). 4. In contrast, the i.t. dose of 5-HT which elevated TFL also produced analgesia on the hot plate test. 5. Serotonin-induced elevations in TFL were reversed by pindolol, ritanserin and ICS 205-930, suggesting that 5-HT interacts with more than one 5-HT site in the spinal cord to produce analgesia on the tail-flick test. 6. The finding that ritanserin reversed 5-HT-induced elevations in HPL suggests that the 5-HT2 site is primarily responsible for mediating the spinal antinociceptive effects of 5-HT on the hot plate test.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829046     DOI: 10.1016/0306-3623(91)90441-8

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  19 in total

1.  Spinal 5-HT-receptors and tonic modulation of transmission through a withdrawal reflex pathway in the decerebrated rabbit.

Authors:  R W Clarke; J Harris; A K Houghton
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Interaction of opioids with antidepressant-induced antinociception.

Authors:  F Sierralta; G Pinardi; M Mendez; H F Miranda
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

3.  Inhibition of opioid release in the rat spinal cord by serotonin 5-HT(1A) receptors.

Authors:  Bingbing Song; Wenling Chen; Juan Carlos G Marvizón
Journal:  Brain Res       Date:  2007-05-08       Impact factor: 3.252

4.  Serotonergic inhibition of the T-type and high voltage-activated Ca2+ currents in the primary sensory neurons of Xenopus larvae.

Authors:  Q Q Sun; N Dale
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

5.  Pronociceptive effect of 5-HT(1A) receptor agonist on visceral pain involves spinal N-methyl-D-aspartate (NMDA) receptor.

Authors:  A Mickle; P Kannampalli; M Bruckert; A Miranda; B Banerjee; J N Sengupta
Journal:  Neuroscience       Date:  2012-05-22       Impact factor: 3.590

6.  Effects of direct- and indirect-acting serotonin receptor agonists on the antinociceptive and discriminative stimulus effects of morphine in rhesus monkeys.

Authors:  Jun-Xu Li; Wouter Koek; Kenner C Rice; Charles P France
Journal:  Neuropsychopharmacology       Date:  2011-01-05       Impact factor: 7.853

7.  Effects of dorsal rhizotomy and selective lesion of serotonergic and noradrenergic systems on 5-HT1A, 5-HT1B, and 5-HT3 receptors in the rat spinal cord.

Authors:  A M Laporte; C M Fattaccini; M C Lombard; J Chauveau; M Hamon
Journal:  J Neural Transm Gen Sect       Date:  1995

8.  Modulation of afferent-evoked neurotransmission by 5-HT3 receptors in young rat dorsal horn neurones in vitro: a putative mechanism of 5-HT3 induced anti-nociception.

Authors:  S G Khasabov; J A Lopez-Garcia; A U Asghar; A E King
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

Review 9.  Preclinical and early clinical investigations related to monoaminergic pain modulation.

Authors:  Kirsty Bannister; Lucy A Bee; Anthony H Dickenson
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  Buspirone-induced antinociception is mediated by L-type calcium channels and calcium/caffeine-sensitive pools in mice.

Authors:  Jian-Hui Liang; Xu-Hua Wang; Rui-Ke Liu; Hong-Lei Sun; Xiang-Feng Ye; Ji-Wang Zheng
Journal:  Psychopharmacology (Berl)       Date:  2003-01-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.